By: Gerard Gallagher, Kristen Dowd
MUNICH — A large observational study involving hundreds of thousands of patients in the United States saw no difference in treatment failure among
Gerard Gallagher is an Editorial Director at Healio. With over 20 years of experience, he specializes in healthcare administration, public health, and health news, while also drawing from his background as a sports writer who covered five Olympics. Gallagher has been featured in Healio, where he contributes to the infectious diseases and pediatrics news teams.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Gerard Gallagher’s coverage primarily focuses on healthcare and pharmaceuticals, with a strong emphasis on infectious diseases, public health, medical research, and vaccines. His articles often cite data and provide expert commentary. To effectively reach out to Gerard Gallagher, consider providing insights or data-backed analysis related to developments in the field of infectious diseases or public health. Experts who can offer valuable perspectives on vaccine development or healthcare preparedness for pandemics would likely be of interest to him.
When reaching out to Gerard Gallagher with pitches for potential stories or expert commentary, it's important to ensure that the content aligns closely with his areas of focus within the healthcare sector. Additionally, given his lack of specified geographic focus but broad international themes covered in healthcare and pharmaceutical fields, he may appreciate insights from global experts as well as those focusing specifically on the US context when relevant.
This information evolves through artificial intelligence and human feedback. Improve this profile .